This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Interdict Bio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sogole Sami Bahmanyar and Small-Molecule Protein Synthesis Modulators.
Introduction
Sogole Sami Bahmanyar is an inventor based in San Francisco, California. His work includes a patent concerning compounds designed to modulate protein synthesis. The available information lists 1 patent associated with him and identifies Interdict Bio, Inc. as his company.
Latest Patents
The patent, “Small Molecule Protein Synthesis Modulators,” describes compounds and their pharmaceutically acceptable salts for modulating protein synthesis. It also covers pharmaceutical compositions and kits containing these compounds.
The disclosure describes potential methods for treating or preventing diseases and disorders by administering the compounds or related compositions. The conditions discussed include those associated with BCL-2, MYC, CCND1, MCL-1, ALK, and KRAS-G12D.
Career Highlights
Bahmanyar’s listed patent work focuses on small-molecule approaches to influencing protein synthesis, with potential applications in disease treatment and prevention. He is associated with Interdict Bio, Inc.
Collaborations
The listed coworkers associated with Bahmanyar are Lawrence Hamann and Zef Konst.
Conclusion
Sogole Sami Bahmanyar’s patent describes protein synthesis modulators and related pharmaceutical applications, reflecting his documented innovation work with Interdict Bio, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile